Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Completed 4Terminated 2

Sponsor Class

NIH 4INDUSTRY 2

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

CNS 6Plasma cell 5Genitourinary 4Thoracic 2Sarcoma 2Other hematologic neoplasm 2Gastrointestinal 2Myeloid 1Lymphoid 1Gynecologic 1Dermatologic 1Breast 1

Conditions

Glioblastoma 380Brain Neoplasms 376Glioma 232Gliosarcoma 147Astrocytoma 138Neuroblastoma 121Central Nervous System Neoplasms 118Oligodendroglioma 80Medulloblastoma 61Breast Neoplasms 52Neoplasms 51Melanoma 45Ependymoma 43Carcinoma, Non-Small-Cell Lung 42Recurrence 40Sarcoma 33Meningioma 33Rhabdomyosarcoma 32Neurofibromatosis 1 32Osteosarcoma 31Neoplasm Metastasis 29Lymphoma, Non-Hodgkin 27Wilms Tumor 26Lung Neoplasms 26Neuroectodermal Tumors, Primitive, Peripheral 25Sarcoma, Ewing 23Lymphoma 22Rhabdoid Tumor 20Hepatoblastoma 19Testicular Neoplasms 17

Interventions

vandetanib 1carotuximab 1Tamoxifen 1Irinotecan 1Carboplatin 1Bortezomib 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Has results × Disease Progression × CNS × Clear all
NCT02392078 2025-04-24

LAANTERN

Monteris Medical

Completed
1,153 enrolled 15 charts
CNS

Brain Neoplasms, Epilepsy, Movement Disorders, Disease Progression

NCT01651078 2024-04-15

LAASR

Monteris Medical

Completed
44 enrolled 8 charts
CNS

Brain Neoplasms, Disease Progression

NCT00995007 2016-03-29

A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
112 enrolled 12 charts
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma, Disease Progression

NCT00108069 2015-11-05

Tamoxifen and Bortezomib to Treat Recurrent Brain Tumors

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
43 enrolled 11 charts
CNS

Brain Neoplasms, Glioma, Neoplasms, Disease Progression

NCT01778530 2015-10-07

TRC105 for Recurrent Glioblastoma

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
2 enrolled 9 charts
CNS

Glioblastoma, Glioma, Disease Progression

NCT00393094 2012-07-13

Bevacizumab and Irinotecan to Treat Brain Tumors

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
31 enrolled 12 charts
CNS

Brain Neoplasms, Glioma, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡